Atrial fibrillation, as a common arrhythmia in COVID-19, can occur due to various conditions such as increased cytokine levels, decreased cardiovascular protection from ACE2-virus interactions, changes in electrolytes and the structure of the atrium caused by the interaction of CD147 and sialic acid-spike protein [53]. This evidence concerns the gene ACE2 and cardiac arrhythmia.